Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC
Clinical trial NCT04543110 · UNKNOWN
Trial details
- NCT number
- NCT04543110
- Sponsor
- Ottawa Hospital Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-29
- Primary completion
- 2023-10-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.